Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GHRS GH Research > Detailed Quotes

GHRS GH Research

Watchlist
9.530
+0.280+3.03%
Close  01/27 16:00 ET
High
9.700
Open
9.330
Turnover
36.99K
Low
9.330
Pre Close
9.250
Volume
3.87K
Market Cap
495.76M
P/E(TTM)
Loss
52wk High
20.340
Shares
52.02M
P/E(Static)
Loss
52wk Low
8.460
Float Cap
122.05M
Bid/Ask %
33.33%
Historical High
30.430
Shs Float
12.81M
Volume Ratio
0.13
Historical Low
8.460
Dividend TTM
--
Div Yield TTM
--
P/B
1.93
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
4.00%
Avg Price
9.570
Lot Size
1
Float Cap
122.05M
Bid/Ask %
33.33%
Historical High
30.430
Shs Float
12.81M
Volume Ratio
0.13
Historical Low
8.460
Dividend TTM
--
P/B
1.93
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
4.00%
Avg Price
9.570
Lot Size
1
Price Forecast

News

Comment

Company Overview More
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch?nharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
CEO: Dr. Theis Terwey
Market: NASDAQ
Listing Date: 06/25/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist